THE COLUMN GROUP
The Column Group is a leading venture capital firm dedicated to creating the next generation of biotechnology companies
THE COLUMN GROUP
Social Links:
Industry:
Biotechnology Finance Financial Services Venture Capital
Founded:
2006-01-01
Status:
Active
Contact:
(415) 255-2048
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Apache Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS CPanel SSL GoDaddy EasyDNS
Similar Organizations
Greenoaks Capital
Greenoaks is a global investment firm specializing in technology companies.
Motley Fool Ventures
Motley Fool Ventures is a venture capital that primarily invests in tech-enabled companies.
Venrock
Venrock is a venture capital firm investing in technology and healthcare companies.
Current Advisors List
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-07-26 | Carmot Therapeutics | The Column Group investment in Series D - Carmot Therapeutics | 160 M USD |
| 2022-05-17 | Remix Therapeutics | The Column Group investment in Series B - Remix Therapeutics | 70 M USD |
| 2022-02-23 | Plexium | The Column Group investment in Series B - Plexium | 102 M USD |
| 2022-02-15 | Kallyope | The Column Group investment in Series D - Kallyope | 236 M USD |
| 2022-01-06 | Eikon Therapeutics | The Column Group investment in Series B - Eikon Therapeutics | 518 M USD |
| 2021-09-22 | Hexagon Bio | The Column Group investment in Series B - Hexagon Bio | 61 M USD |
| 2021-09-09 | Obsidian Therapeutics | The Column Group investment in Series B - Obsidian Therapeutics | 115 M USD |
| 2021-08-26 | Effector Therapeutics | The Column Group investment in Post-IPO Equity - Effector Therapeutics | 60 M USD |
| 2021-08-24 | Atavistik Bio | The Column Group investment in Series A - Atavistik Bio | 60 M USD |
| 2021-08-12 | Surrozen | The Column Group investment in Post-IPO Equity - Surrozen | 120 M USD |
More informations about "The Column Group"
The Column Group - Crunchbase Investor Profile
The Column Group is a venture capital firm dedicated to creating the next generation of biotechnology companies. They manage over $4 billion in assets and focus on building companies with groundbreaking scientific platforms that …See details»
Team - The Column Group
Prior to joining The Column Group, Dr. Kutzkey was a scientist at KAI Pharmaceuticals where he focused on the discovery and development of selective protein kinase C inhibitors. ... European Molecular Biology …See details»
The Column Group Raises $1.23 Billion in Two New Funds
The Column Group is a leading venture capital firm based in San Francisco that seeks to partner with exceptional scientific founders, entrepreneurs, executives, and investment organizations …See details»
The Column Group - The Org
The Column Group (TCG) is a science-driven venture capital firm that makes significant financial and operational commitments to build early-stage drug discovery companies based on their unique scientific platforms and potential …See details»
The Column Group, LLC - VentureRadar
Jun 3, 2024 The Column Group (TCG) is a science-driven venture capital firm managing $4.0 billion in assets, dedicated to investing in early stage biotechnology companies focused on …See details»
The Column Group - LinkedIn
The Column Group (TCG) is a science-driven venture capital firm that makes significant financial and operational commitments to build early stage drug discovery companies based on their unique ...See details»
The Column Group - Investments, Portfolio & Company Exits
The Column Group 's most notable exits include ORIC Pharmaceuticals, Sagimet Biosciences, and Nurix Therapeutics. ... Revolution Medicines Revolution Medicines is an innovative and …See details»
The Column Group - Funding, Financials, Valuation & Investors
The Column Group is a venture capital firm dedicated to developing biotechnology companies.See details»
The Column Group investment portfolio - PitchBook
Dec 17, 2023 The Column Group General Information Company Description. Founded in 2007, The Column Group is a venture capital investment firm based in San Francisco, California. The firm prefers to invest in seed-stage and early …See details»
The Column Group Raises a $725 Million Fourth Fund
The Column Group is a leading venture capital firm based in San Francisco that seeks to partner with exceptional scientific founders, entrepreneurs, executives, and investment organizations …See details»
Investing in Medicine with The Column Group - Excedr
The Column Group Team. The Column Group has a diverse group of professionals with varied experience in creating, operating, and funding biotechnology and Life Science companies in …See details»
The Column Group - Overview, News & Similar companies
Feb 27, 2022 The Column Group (TCG) is a leading venture capital firm based in San Francisco that seeks to partner with exceptional scientific founders, entrepr eneurs, executives, and …See details»
The Column Group Information - RocketReach
The SIC codes for The Column Group are [67, 679, 6799]. Top The Column Group Employees Tim Kutzkey Managing Partner at The Column Group San Francisco, CA, US View. 3 …See details»
TCG News - The Column Group
Jun 9, 2022 The Column Group announces the hiring of Dr. Arnav Mehta. Previously, Dr. Mehta was an Entrepreneur-in-Residence at Third Rock Ventures, a gastrointestinal oncologist at …See details»
The Column Group - Contacts, Employees, Board Members
The Column Group has 22 current employee profiles, including Chief Financial Officer James Evangelista. The Column Group has 1 board member or advisor, Grant Heidrich . ContactsSee details»
News - The Column Group
Nov 1, 2024 The Column Group announces the hiring of Dr. Arnav Mehta. Previously, Dr. Mehta was an Entrepreneur-in-Residence at Third Rock Ventures, a gastrointestinal oncologist at …See details»
Organize Data in Excel: A Complete Guide - ExcelDemy
Jul 4, 2024 Case 1.2 – Sorting Multiple Columns. Let’s arrange the data by age, then by city, then by name. Select anywhere in your dataset. Go to Data, then choose Sort & Filter and …See details»
Portfolio - The Column Group
Revolution Medicines is an innovative and dynamic organization of expert cellular, structural and computational biologists, medicinal and synthetic chemists, pharmacologists, engineers and …See details»
Peter Svennilson - Managing Partner and Founder @ The Column …
Peter Svennilson is the Managing Partner and Founder of The Column Group, a biotech VC fund based in San Francisco. He has 23 years of experience in corporate finance, investment …See details»